Cycle tracking wearables are being asked to prove clinical grade accuracy, not just convenience
Dr. Dereck Mush, MD, MBA
What they do
Brellium raised $23M in October 2026, co-led by Left Lane Capital and First Round Capital, and launched CortexLM, a chart-auditing system that reads every note and proposes fixes before claims go out. It has audited 22 million visits for more than 200 provider groups across all 50 states and is expanding into cardiology, pain management and primary care.
The record
- Vertical
- Admin & Revenue Cycle
- Sub-segment
- Clinical compliance AI
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- New York, USA
- Region
- North America
- Founded
- 2021
- Total funding
- $40M raised
Notable investors: Left Lane Capital, First Round Capital, Digital Health Venture Partners.
Related on The Signal
Dr. Dereck Mush, MD, MBA
Beyond the Scribe: How Ambient AI Is Morphing into Point-of-Care Clinical Reasoning and EHR Operating Systems
Dr. Dereck Mush, MD, MBA
The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBA
From IT Expense to Revenue Driver: How CMS NTAP Activates the Clinical AI Commercial Flywheel
Dr. Dereck Mush, MD, MBA